Skip to content

Clinical Efficacy Observation of Pneumatic Retinopexy in the Treatment of Rhegmatogenous Retinal Detachment

Clinical Efficacy Observation of Pneumatic Retinopexy in the Treatment of Rhegmatogenous Retinal Detachment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112729
Enrollment
Unknown
Registered
2025-11-19
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhegmatogenous Retinal Detachment

Interventions

Pneumatic Retinopexy group:Intravitreal injection of filtered air 0.5~0.6ml
Scleral buckling group:Scleral buckling, cryopexy, and subretinal fluid drainage

Sponsors

Senior Department of Ophthalmology, the Third Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Confirmed diagnosis of rhegmatogenous retinal detachment (RRD) with disease duration within 1 month, proliferative vitreoretinopathy (PVR) = Grade B; 3. Single retinal break <2 disc diameters (DD) in size or multiple breaks confined to less than 1 quadrant; 4. Absence of severe ocular or systemic comorbidities; 5. Signed informed consent form obtained from the patient or legal guardian.

Exclusion criteria

Exclusion criteria: 1. Presence of vitreous hemorrhage and/or other conditions impairing fundus visualization; 2.Non-rhegmatogenous retinal detachment; 3.Retinal break(s) >2 disc diameters (DD) in size or multiple breaks involving =1 quadrant; 4. Macular hole retinal detachment. 5.Proliferative vitreoretinopathy (PVR) of Grade C or D; 6.Glaucoma or aphakia; 7.Inability to comply with postoperative head positioning requirements.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity (BCVA);Intraocular pressure (IOP);Fundus photography;Ophthalmic ultrasound examination;Macular optical coherence tomography;

Countries

China

Contacts

Public ContactJin Xin

Senior Department of Ophthalmology, the Third Medical Center of Chinese PLA General Hospitalospital

13910195023@sina.cn+86 10 5797 5104

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026